Search alternatives:
significant adverse » significant advantage (Expand Search), significant decrease (Expand Search)
adverse decrease » rivers decreased (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), teer decrease (Expand Search)
significant adverse » significant advantage (Expand Search), significant decrease (Expand Search)
adverse decrease » rivers decreased (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), teer decrease (Expand Search)
-
1
-
2
-
3
-
4
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
5
-
6
Study-related adverse events.
Published 2025“…In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
7
-
8
-
9
-
10
Key safety measures including adverse events.
Published 2025“…Waist circumference (mean change (MC) −2.23 cm; 95% CI [−3.98, −0.49]; <i>p</i> = 0.01), BMI (MC −0.49 kg/m<sup>2</sup>; 95% CI [−0.88, −0.10[; <i>p</i> = 0.01), and android fat mass measured by DXA (MC −167 g; 95% CI [−264, −71[; <i>p</i> < 0.001) decreased in the COCP group over the study period whilst there was no statistically significant changes in these parameters in the metformin only group when compared to baseline.. …”
-
11
-
12
Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count.
Published 2025“…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20